Oral VV261 administration protects mice from lethal Crimean-Congo hemorrhagic fever virus challenge. [PDF]
Wang X +10 more
europepmc +1 more source
This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Crimean-Congo hemorrhagic fever virus, Viral hemorrhagic fevers cases.
core
Detection of Crimean-Congo hemorrhagic fever virus and Rift Valley fever virus antibodies in animal workers in Cameroon. [PDF]
Machuetum GL +19 more
europepmc +1 more source
This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Crimean-Congo hemorrhagic fever virus, Viral hemorrhagic fevers cases.
core
Genetic Variations in Crimean-Congo Hemorrhagic Fever Virus: Challenges for Molecular Diagnostic Assays-A Case Report. [PDF]
Salehi-Vaziri M +11 more
europepmc +1 more source
This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Crimean-Congo hemorrhagic fever virus, Viral hemorrhagic fevers cases.
core
Soluble MFGE8 mediates cell entry of Crimean-Congo hemorrhagic fever virus. [PDF]
Ma X +15 more
europepmc +1 more source
Serologic evidence of crimean-congo hemorrhagic fever virus exposure among livestock and farmers in the Democratic Republic of the Congo. [PDF]
Halbrook M +17 more
europepmc +1 more source
A single-dose mRNA vaccine protects mice from lethal Crimean-Congo hemorrhagic fever virus infection. [PDF]
Rao J +15 more
europepmc +1 more source
Crimean-Congo hemorrhagic fever virus NSm protein inhibits the type I interferon signaling by binding to STAT2. [PDF]
Yoshikawa R +4 more
europepmc +1 more source

